1,186 records
How long has this drug been in shortage?
Across 1,186 records covering 1,183 package NDCs, days in shortage runs from 5 (0409-0801-01) to 5357 (25 package NDCs), and 1145 is the most common — 98 of them. Every value is transcribed from the source that states it and carries the sentence it was taken from: 292 sources across 1 site, last checked 2026-09-16, due for re-check by 2026-09-19. Every record has a page of its own, quoting the line that states it.
About this data
For every package FDA currently lists as in shortage: how long that shortage entry has been open (from openFDA's own `initial_posting_date` to today), what FDA says the package's supply is right now, and any recovery estimate FDA has given. What FDA itself publishes, checked directly on 2026-09-01 rather than assumed: the shortage list page (accessdata.fda.gov/scripts/drugshortages) shows which drugs are short and why and carries no date at all, while each per-drug detail page adds a single 'Date first posted' for the whole drug. Neither prints an elapsed duration, and neither gives the date per manufacturer. openFDA does — where several manufacturers report a shortage of the same drug, each carries its own posting date, and FDA's page shows only the earliest of them. Cross-checked across 30 drugs against those detail pages: 30 of 30 agreed, and in all 10 multi-manufacturer cases FDA's single date was exactly the earliest of ours. The underlying facts are FDA's own public-domain data; the duration is a computation over them that nobody publishes maintained, because it changes every day and hand-updating it was never worth the effort. A scheduled refetch of the same public API keeps it current for free. Read the duration next to `availability`, and do not read it alone: a shortage entry stays 'Current' until FDA resolves the whole shortage, so 63.8% of listed packages (746 of 1,169, measured 2026-09-01) are marked 'Available' even while their entry has been open for years — the median entry has been open 1,721 days and 1,118 of 1,169 have been open more than 1,000. Records cite a per-drug, per-manufacturer API query rather than a page offset, because openFDA's result ordering rotates daily and an offset URL stops containing its own record — see sources.txt. Source: https://api.fda.gov/drug/shortages.json (openFDA, no API key required at this volume). This is a monitored dataset, not a static page — stale_after_days is short and a build should re-run the fetch on a schedule rather than once.
The data
| Package NDC | Generic name | Manufacturer | Status | Availability now | FDA note | Initial posting date | Last update date | Days in shortage | Reason for shortage | Dosage form | Therapeutic category |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 16729-483-03 | Atropine Sulfate Injection | Accord Healthcare Inc. | Current | Unavailable | Discontinuation of the manufacture of the drug | 01/01/2020 | 08/17/2026 | 2435 | Discontinuation of the manufacture of the drug | Injection | Anesthesia |
| 16729-484-45 | Atropine Sulfate Injection | Accord Healthcare Inc. | Current | Available | 01/01/2020 | 08/17/2026 | 2435 | Injection | Anesthesia | ||
| 16729-484-90 | Atropine Sulfate Injection | Accord Healthcare Inc. | Current | Unavailable | Discontinuation of the manufacture of the drug | 01/01/2020 | 08/17/2026 | 2435 | Discontinuation of the manufacture of the drug | Injection | Anesthesia |
| 16729-512-43 | Atropine Sulfate Injection | Accord Healthcare Inc. | Current | Unavailable | Estimated recovery: TBD | 01/01/2012 | 08/17/2026 | 5357 | Requirements related to complying with good manufacturing practices | Injection | Anesthesia |
| 16729-525-08 | Atropine Sulfate Injection | Accord Healthcare Inc. | Current | Unavailable | Estimated recovery: September 2026 | 01/01/2012 | 08/17/2026 | 5357 | Requirements related to complying with good manufacturing practices | Injection | Anesthesia |
| 16729-526-08 | Atropine Sulfate Injection | Accord Healthcare Inc. | Current | Unavailable | Estimated recovery: TBD | 01/01/2012 | 08/17/2026 | 5357 | Requirements related to complying with good manufacturing practices | Injection | Anesthesia |
| 16729-306-10 | Azacitidine Injection | Accord Healthcare Inc. | Current | Available | 12/21/2020 | 08/17/2026 | 2080 | Injection | Oncology | ||
| 16729-295-12 | Carboplatin Injection | Accord Healthcare Inc. | Current | Unavailable | Estimated recovery: TBD; NDC is non-exempt | 04/28/2023 | 08/17/2026 | 1222 | Requirements related to complying with good manufacturing practices | Injection | Oncology |
| 16729-295-31 | Carboplatin Injection | Accord Healthcare Inc. | Current | Unavailable | Discontinuation of the manufacture of the drug | 04/28/2023 | 08/17/2026 | 1222 | Discontinuation of the manufacture of the drug | Injection | Oncology |
| 16729-295-33 | Carboplatin Injection | Accord Healthcare Inc. | Current | Unavailable | Estimated recovery: TBD; NDC is non-exempt | 04/28/2023 | 08/17/2026 | 1222 | Discontinuation of the manufacture of the drug | Injection | Oncology |
| 16729-295-34 | Carboplatin Injection | Accord Healthcare Inc. | Current | Unavailable | Estimated recovery: TBD; NDC is non-exempt | 04/28/2023 | 08/17/2026 | 1222 | Requirements related to complying with good manufacturing practices | Injection | Oncology |
| 16729-136-00 | Clonazepam Tablet | Accord Healthcare Inc. | Current | Available | 03/10/2023 | 08/17/2026 | 1271 | Tablet | Neurology | ||
| 16729-136-16 | Clonazepam Tablet | Accord Healthcare Inc. | Current | Available | 03/10/2023 | 08/17/2026 | 1271 | Tablet | Neurology | ||
| 16729-137-00 | Clonazepam Tablet | Accord Healthcare Inc. | Current | Available | 03/10/2023 | 08/17/2026 | 1271 | Tablet | Neurology | ||
| 16729-137-16 | Clonazepam Tablet | Accord Healthcare Inc. | Current | Available | 03/10/2023 | 08/17/2026 | 1271 | Tablet | Neurology | ||
| 16729-138-00 | Clonazepam Tablet | Accord Healthcare Inc. | Current | Available | 03/10/2023 | 08/17/2026 | 1271 | Tablet | Neurology | ||
| 16729-138-16 | Clonazepam Tablet | Accord Healthcare Inc. | Current | Available | 03/10/2023 | 08/17/2026 | 1271 | Tablet | Neurology | ||
| 16729-239-93 | Dexmedetomidine Hydrochloride Injection | Accord Healthcare Inc. | Current | Unavailable | Discontinuation of the manufacture of the drug | 04/10/2020 | 08/17/2026 | 2335 | Discontinuation of the manufacture of the drug | Injection | Anesthesia |
| 16729-432-93 | Dexmedetomidine Hydrochloride Injection | Accord Healthcare Inc. | Current | Unavailable | Discontinuation of the manufacture of the drug | 04/10/2020 | 08/17/2026 | 2335 | Discontinuation of the manufacture of the drug | Injection | Anesthesia |
| 16729-500-08 | Furosemide Injection | Accord Healthcare Inc. | Current | Unavailable | Estimated recovery: TBD; NDC is non-exempt | 04/07/2020 | 08/17/2026 | 2338 | Requirements related to complying with good manufacturing practices | Injection | Cardiovascular |
| 16729-501-43 | Furosemide Injection | Accord Healthcare Inc. | Current | Unavailable | Estimated recovery: TBD; NDC is non-exempt | 04/07/2020 | 08/17/2026 | 2338 | Requirements related to complying with good manufacturing practices | Injection | Cardiovascular |
| 16729-502-43 | Furosemide Injection | Accord Healthcare Inc. | Current | Unavailable | Estimated recovery: TBD; NDC is non-exempt | 04/07/2020 | 08/17/2026 | 2338 | Requirements related to complying with good manufacturing practices | Injection | Cardiovascular |
| 16729-277-30 | Methotrexate Sodium Injection | Accord Healthcare Inc. | Current | Available | 03/13/2023 | 08/17/2026 | 1268 | Injection | Rheumatology | ||
| 16729-277-35 | Methotrexate Sodium Injection | Accord Healthcare Inc. | Current | Available | 03/13/2023 | 08/17/2026 | 1268 | Injection | Rheumatology | ||
| 69784-200-96 | Cromolyn Sodium Concentrate | Ailex Pharmaceuticals | Current | Limited Availability | No longer manufactured, some supplies still available in supply chain. Distributed by Woodward Pharma Services LLC (248) 308-1120 Ext 2 | 11/03/2023 | 07/17/2026 | 1033 | Other | Concentrate | Pulmonary/Allergy |
| 76204-025-96 | Cromolyn Sodium Concentrate | Ailex Pharmaceuticals | Current | Limited Availability | No longer manufactured, some supplies still available in supply chain. Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300 | 11/03/2023 | 07/17/2026 | 1033 | Other | Concentrate | Pulmonary/Allergy |
| 81665-104-96 | Cromolyn Sodium Concentrate | Ailex Pharmaceuticals | Current | Available | Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195 | 11/03/2023 | 07/17/2026 | 1033 | Concentrate | Pulmonary/Allergy | |
| 62332-599-25 | Ketorolac Tromethamine Injection | Alembic Pharmaceuticals | Current | Available | 03/23/2018 | 05/15/2026 | 3084 | Injection | Analgesia/Addiction | ||
| 62332-600-25 | Ketorolac Tromethamine Injection | Alembic Pharmaceuticals | Current | Available | 03/23/2018 | 05/15/2026 | 3084 | Injection | Analgesia/Addiction | ||
| 62332-601-25 | Ketorolac Tromethamine Injection | Alembic Pharmaceuticals | Current | Available | 03/23/2018 | 05/15/2026 | 3084 | Injection | Analgesia/Addiction | ||
| 47781-174-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 47781-176-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 47781-178-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 47781-179-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 47781-180-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Alvogen | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 47781-562-01 | Lisdexamfetamine Dimesylate Capsule | Alvogen | Current | Available | 07/14/2023 | 08/17/2026 | 1145 | Capsule | Psychiatry | ||
| 47781-563-01 | Lisdexamfetamine Dimesylate Capsule | Alvogen | Current | Available | 07/14/2023 | 08/17/2026 | 1145 | Capsule | Psychiatry | ||
| 47781-564-01 | Lisdexamfetamine Dimesylate Capsule | Alvogen | Current | Available | 07/14/2023 | 08/17/2026 | 1145 | Capsule | Psychiatry | ||
| 47781-565-01 | Lisdexamfetamine Dimesylate Capsule | Alvogen | Current | Available | 07/14/2023 | 08/17/2026 | 1145 | Capsule | Psychiatry | ||
| 47781-566-01 | Lisdexamfetamine Dimesylate Capsule | Alvogen | Current | Available | 07/14/2023 | 08/17/2026 | 1145 | Capsule | Psychiatry | ||
| 47781-567-01 | Lisdexamfetamine Dimesylate Capsule | Alvogen | Current | Available | 07/14/2023 | 08/17/2026 | 1145 | Capsule | Psychiatry | ||
| 47781-568-01 | Lisdexamfetamine Dimesylate Capsule | Alvogen | Current | Available | 07/14/2023 | 08/17/2026 | 1145 | Capsule | Psychiatry | ||
| 0517-1001-25 | Atropine Sulfate Injection | American Regent, Inc. | Current | Available | 01/01/2012 | 08/17/2026 | 5357 | Injection | Anesthesia | ||
| 0517-1004-25 | Atropine Sulfate Injection | American Regent, Inc. | Current | Available | 01/01/2012 | 08/17/2026 | 5357 | Injection | Anesthesia | ||
| 70121-1388-1 | Dexmedetomidine Hydrochloride Injection | Amneal Pharmaceuticals | Current | Available | 04/10/2020 | 06/17/2026 | 2335 | Injection | Anesthesia | ||
| 70121-1388-8 | Dexmedetomidine Hydrochloride Injection | Amneal Pharmaceuticals | Current | Available | Inventory available 4 to 5 month as per current demand. Next supply: week of 06/29/2026 | 04/10/2020 | 06/17/2026 | 2335 | Injection | Anesthesia | |
| 70121-1389-1 | Dexmedetomidine Hydrochloride Injection | Amneal Pharmaceuticals | Current | Available | 04/10/2020 | 06/17/2026 | 2335 | Injection | Anesthesia | ||
| 70121-1389-7 | Dexmedetomidine Hydrochloride Injection | Amneal Pharmaceuticals | Current | Available | 04/10/2020 | 06/17/2026 | 2335 | Injection | Anesthesia | ||
| 65162-023-09 | Lisdexamfetamine Dimesylate Capsule | Amneal Pharmaceuticals | Current | Available | 07/14/2023 | 06/17/2026 | 1145 | Capsule | Psychiatry | ||
| 65162-024-09 | Lisdexamfetamine Dimesylate Capsule | Amneal Pharmaceuticals | Current | Available | 07/14/2023 | 06/17/2026 | 1145 | Capsule | Psychiatry | ||
| 65162-025-09 | Lisdexamfetamine Dimesylate Capsule | Amneal Pharmaceuticals | Current | Available | 07/14/2023 | 06/17/2026 | 1145 | Capsule | Psychiatry | ||
| 65162-026-09 | Lisdexamfetamine Dimesylate Capsule | Amneal Pharmaceuticals | Current | Available | 07/14/2023 | 06/17/2026 | 1145 | Capsule | Psychiatry | ||
| 65162-027-09 | Lisdexamfetamine Dimesylate Capsule | Amneal Pharmaceuticals | Current | Available | 07/14/2023 | 06/17/2026 | 1145 | Capsule | Psychiatry | ||
| 65162-028-09 | Lisdexamfetamine Dimesylate Capsule | Amneal Pharmaceuticals | Current | Available | 07/14/2023 | 06/17/2026 | 1145 | Capsule | Psychiatry | ||
| 70121-1573-1 | Methylprednisolone Acetate Injection | Amneal Pharmaceuticals | Current | Limited Availability | On backorder. Estimated recovery: late July | 12/15/2021 | 06/17/2026 | 1721 | Other | Injection | Rheumatology |
| 70121-1573-5 | Methylprednisolone Acetate Injection | Amneal Pharmaceuticals | Current | Available | 12/15/2021 | 06/17/2026 | 1721 | Injection | Rheumatology | ||
| 70121-1574-1 | Methylprednisolone Acetate Injection | Amneal Pharmaceuticals | Current | Available | 12/15/2021 | 06/17/2026 | 1721 | Injection | Rheumatology | ||
| 70121-1574-5 | Methylprednisolone Acetate Injection | Amneal Pharmaceuticals | Current | Available | 12/15/2021 | 06/17/2026 | 1721 | Injection | Rheumatology | ||
| 76329-3340-1 | Atropine Sulfate Injection | Amphastar Pharmaceuticals, Inc. | Current | Available | 01/01/2020 | 08/18/2026 | 2435 | Injection | Anesthesia | ||
| 76329-3302-1 | Dextrose Monohydrate 50% Injection | Amphastar Pharmaceuticals, Inc. | Current | Available | 01/13/2022 | 08/18/2026 | 1692 | Injection | Endocrinology/Metabolism | ||
| 76329-3390-1 | Lidocaine Hydrochloride Injection | Amphastar Pharmaceuticals, Inc. | Current | Limited Availability | Available on allocation | 02/22/2012 | 08/18/2026 | 5305 | Demand increase for the drug | Injection | Anesthesia |
| 76329-8261-1 | Lorazepam Injection | Amphastar Pharmaceuticals, Inc. | Current | Available | 05/03/2018 | 08/18/2026 | 3043 | Injection | Neurology | ||
| 76329-1912-1 | Morphine Sulfate Injection | Amphastar Pharmaceuticals, Inc. | Current | Available | 12/06/2018 | 08/18/2026 | 2826 | Injection | Analgesia/Addiction | ||
| 76329-3352-1 | Sodium Bicarbonate Injection | Amphastar Pharmaceuticals, Inc. | Current | Limited Availability | Available on allocation | 03/01/2017 | 08/18/2026 | 3471 | Demand increase for the drug | Injection | Endocrinology/Metabolism |
| 83634-651-10 | Lidocaine Hydrochloride Injection | Anthea Pharma | Current | Available | Distributed by Avenacy, LLC | 02/22/2012 | 08/04/2026 | 5305 | Injection | Anesthesia | |
| 83634-651-20 | Lidocaine Hydrochloride Injection | Anthea Pharma | Current | Available | Distributed by Avenacy, LLC | 02/22/2012 | 08/04/2026 | 5305 | Injection | Anesthesia | |
| 83634-651-50 | Lidocaine Hydrochloride Injection | Anthea Pharma | Current | Available | Distributed by Avenacy, LLC | 02/22/2012 | 08/04/2026 | 5305 | Injection | Anesthesia | |
| 83634-653-02 | Lidocaine Hydrochloride Injection | Anthea Pharma | Current | Available | Distributed by Avenacy, LLC | 02/22/2012 | 08/04/2026 | 5305 | Injection | Anesthesia | |
| 83634-653-05 | Lidocaine Hydrochloride Injection | Anthea Pharma | Current | Available | Distributed by Avenacy, LLC | 02/22/2012 | 08/04/2026 | 5305 | Injection | Anesthesia | |
| 83634-653-30 | Lidocaine Hydrochloride Injection | Anthea Pharma | Current | Available | Distributed by Avenacy, LLC | 02/22/2012 | 08/04/2026 | 5305 | Injection | Anesthesia | |
| 60505-0815-0 | Desmopressin Acetate Spray | Apotex Corp. | Current | Unavailable | Estimated recovery: 9/7/26 | 03/12/2021 | 08/24/2026 | 1999 | Delay in shipping of the drug | Spray | Hematology |
| 60505-4739-1 | Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Current | Available | 11/01/2023 | 08/24/2026 | 1035 | Capsule | Psychiatry | ||
| 60505-4740-1 | Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Current | Limited Availability | Estimated recovery: 10/20/26 | 11/01/2023 | 08/24/2026 | 1035 | Delay in shipping of the drug | Capsule | Psychiatry |
| 60505-4741-1 | Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Current | Available | 11/01/2023 | 08/24/2026 | 1035 | Capsule | Psychiatry | ||
| 60505-4742-1 | Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Current | Available | 11/01/2023 | 08/24/2026 | 1035 | Capsule | Psychiatry | ||
| 60505-4743-1 | Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Current | Unavailable | Estimated recovery: Week of 8/24/26 | 11/01/2023 | 08/24/2026 | 1035 | Delay in shipping of the drug | Capsule | Psychiatry |
| 60505-4744-1 | Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Current | Available | 11/01/2023 | 08/24/2026 | 1035 | Capsule | Psychiatry | ||
| 60505-4745-1 | Lisdexamfetamine Dimesylate Capsule | Apotex Corp. | Current | Available | 11/01/2023 | 08/24/2026 | 1035 | Capsule | Psychiatry | ||
| 72485-201-01 | Azacitidine Injection | Armas Pharmaceuticals Inc | Current | Limited Availability | Estimated recovery: TBD | 12/18/2020 | 06/08/2026 | 2083 | Other | Injection | Oncology |
| 31722-275-32 | Bupivacaine Hydrochloride Injection | Aspiro Pharma Limited | Current | Available | 02/20/2018 | 07/17/2026 | 3115 | Injection | Anesthesia | ||
| 31722-275-34 | Bupivacaine Hydrochloride Injection | Aspiro Pharma Limited | Current | Available | 02/20/2018 | 07/17/2026 | 3115 | Injection | Anesthesia | ||
| 31722-276-32 | Bupivacaine Hydrochloride Injection | Aspiro Pharma Limited | Current | Available | 02/20/2018 | 07/17/2026 | 3115 | Injection | Anesthesia | ||
| 31722-276-34 | Bupivacaine Hydrochloride Injection | Aspiro Pharma Limited | Current | Available | 02/20/2018 | 07/17/2026 | 3115 | Injection | Anesthesia | ||
| 31722-277-32 | Bupivacaine Hydrochloride Injection | Aspiro Pharma Limited | Current | Available | 02/20/2018 | 07/17/2026 | 3115 | Injection | Anesthesia | ||
| 31722-277-34 | Bupivacaine Hydrochloride Injection | Aspiro Pharma Limited | Current | Available | 02/20/2018 | 07/17/2026 | 3115 | Injection | Anesthesia | ||
| 13107-068-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Current | Unavailable | Estimated availability: October 2026 | 10/12/2022 | 07/21/2026 | 1420 | Shortage of an active ingredient | Tablet | Psychiatry |
| 13107-069-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Current | Unavailable | Estimated availability: October 2026 | 10/12/2022 | 07/21/2026 | 1420 | Shortage of an active ingredient | Tablet | Psychiatry |
| 13107-070-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Current | Unavailable | Estimated availability: October 2026 | 10/12/2022 | 07/21/2026 | 1420 | Shortage of an active ingredient | Tablet | Psychiatry |
| 13107-072-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Current | Unavailable | Estimated availability: October 2026 | 10/12/2022 | 07/21/2026 | 1420 | Shortage of an active ingredient | Tablet | Psychiatry |
| 13107-073-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Current | Unavailable | Estimated availability: October 2026 | 10/12/2022 | 07/21/2026 | 1420 | Shortage of an active ingredient | Tablet | Psychiatry |
| 13107-074-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Aurobindo Pharma USA | Current | Unavailable | Estimated availability: October 2026 | 10/12/2022 | 07/21/2026 | 1420 | Shortage of an active ingredient | Tablet | Psychiatry |
| 59651-722-01 | Clonazepam Tablet | Aurobindo Pharma USA | Current | Available | 03/10/2023 | 06/02/2026 | 1271 | Tablet | Neurology | ||
| 59651-722-99 | Clonazepam Tablet | Aurobindo Pharma USA | Current | Available | 03/10/2023 | 06/02/2026 | 1271 | Tablet | Neurology | ||
| 59651-723-01 | Clonazepam Tablet | Aurobindo Pharma USA | Current | Available | 03/10/2023 | 06/02/2026 | 1271 | Tablet | Neurology | ||
| 59651-723-99 | Clonazepam Tablet | Aurobindo Pharma USA | Current | Available | 03/10/2023 | 06/02/2026 | 1271 | Tablet | Neurology | ||
| 59651-724-01 | Clonazepam Tablet | Aurobindo Pharma USA | Current | Available | 03/10/2023 | 06/02/2026 | 1271 | Tablet | Neurology | ||
| 59651-724-05 | Clonazepam Tablet | Aurobindo Pharma USA | Current | Available | 03/10/2023 | 06/02/2026 | 1271 | Tablet | Neurology | ||
| 65862-617-90 | Quinapril Hydrochloride Tablet | Aurobindo Pharma USA | Current | Unavailable | Discontinuation of the manufacture of the drug | 01/19/2023 | 06/02/2026 | 1321 | Discontinuation of the manufacture of the drug | Tablet | Cardiovascular |
| 65862-618-90 | Quinapril Hydrochloride Tablet | Aurobindo Pharma USA | Current | Unavailable | Discontinuation of the manufacture of the drug | 01/19/2023 | 06/02/2026 | 1321 | Discontinuation of the manufacture of the drug | Tablet | Cardiovascular |
| 65862-620-90 | Quinapril Hydrochloride Tablet | Aurobindo Pharma USA | Current | Unavailable | Discontinuation of the manufacture of the drug | 01/19/2023 | 06/02/2026 | 1321 | Discontinuation of the manufacture of the drug | Tablet | Cardiovascular |
| 65862-161-90 | Quinapril/Hydrochlorothiazide Tablet | Aurobindo Pharma USA | Current | Unavailable | Discontinuation of the manufacture of the drug | 01/19/2023 | 06/02/2026 | 1321 | Discontinuation of the manufacture of the drug | Tablet | Cardiovascular |
| 65862-162-90 | Quinapril/Hydrochlorothiazide Tablet | Aurobindo Pharma USA | Current | Unavailable | Discontinuation of the manufacture of the drug | 01/19/2023 | 06/02/2026 | 1321 | Discontinuation of the manufacture of the drug | Tablet | Cardiovascular |
| 65862-163-90 | Quinapril/Hydrochlorothiazide Tablet | Aurobindo Pharma USA | Current | Unavailable | Discontinuation of the manufacture of the drug | 01/19/2023 | 06/02/2026 | 1321 | Discontinuation of the manufacture of the drug | Tablet | Cardiovascular |
| 23155-473-41 | Furosemide Injection | Avet Pharmaceuticals, Inc. | Current | Available | 04/07/2020 | 08/18/2026 | 2338 | Injection | Cardiovascular | ||
| 23155-473-42 | Furosemide Injection | Avet Pharmaceuticals, Inc. | Current | Unavailable | Estimated recovery: late October 2026; Manufacturing delay | 04/07/2020 | 08/18/2026 | 2338 | Other | Injection | Cardiovascular |
| 23155-473-44 | Furosemide Injection | Avet Pharmaceuticals, Inc. | Current | Unavailable | Estimated recovery: late October 2026; Manufacturing delay | 04/07/2020 | 08/18/2026 | 2338 | Other | Injection | Cardiovascular |
| 23155-600-41 | Midazolam Hydrochloride Injection | Avet Pharmaceuticals, Inc. | Current | Limited Availability | Estimated recovery: 8/25/2026 | 04/02/2020 | 08/18/2026 | 2343 | Demand increase for the drug | Injection | Anesthesia |
| 23155-601-41 | Midazolam Hydrochloride Injection | Avet Pharmaceuticals, Inc. | Current | Available | 04/02/2020 | 08/18/2026 | 2343 | Injection | Anesthesia | ||
| 23155-601-42 | Midazolam Hydrochloride Injection | Avet Pharmaceuticals, Inc. | Current | Available | 04/02/2020 | 08/18/2026 | 2343 | Injection | Anesthesia | ||
| 83831-141-08 | Carboplatin Injection | Avyxa Pharma, LLC | Current | Available | 04/28/2023 | 08/04/2026 | 1222 | Injection | Oncology | ||
| 83831-142-50 | Carboplatin Injection | Avyxa Pharma, LLC | Current | Available | 04/28/2023 | 08/04/2026 | 1222 | Injection | Oncology | ||
| 52536-125-10 | Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Current | Available | Distributed by Wilshire Pharmaceuticals, Inc. | 04/10/2020 | 08/17/2026 | 2335 | Injection | Anesthesia | |
| 52536-126-08 | Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Current | Available | Distributed by Wilshire Pharmaceuticals, Inc. | 04/10/2020 | 08/17/2026 | 2335 | Injection | Anesthesia | |
| 72572-127-10 | Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Current | Available | Distributed by Civica | 04/10/2020 | 08/17/2026 | 2335 | Injection | Anesthesia | |
| 72572-128-08 | Dexmedetomidine Hydrochloride Injection | Azurity Pharmaceuticals, Inc | Current | Available | Distributed by Civica | 04/10/2020 | 08/17/2026 | 2335 | Injection | Anesthesia | |
| 0264-1933-10 | Amino Acid Injection | B. Braun Medical Inc. | Current | Available | 12/08/2020 | 08/21/2026 | 2093 | Injection | Gastroenterology | ||
| 0264-4500-00 | Amino Acid Injection | B. Braun Medical Inc. | Current | Available | 12/08/2020 | 08/21/2026 | 2093 | Injection | Gastroenterology | ||
| 0264-4500-05 | Amino Acid Injection | B. Braun Medical Inc. | Current | Available | 12/08/2020 | 08/21/2026 | 2093 | Injection | Gastroenterology | ||
| 0264-1510-31 | Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Current | Available | 02/14/2022 | 08/21/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0264-1510-32 | Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Current | Available | 02/14/2022 | 08/21/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0264-7510-00 | Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Current | Available | 02/14/2022 | 08/21/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0264-7510-10 | Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Current | Available | 02/14/2022 | 08/21/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0264-7510-20 | Dextrose Monohydrate 5% Injection | B. Braun Medical Inc. | Current | Available | 02/14/2022 | 08/21/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0264-7520-00 | Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Current | Available | 03/01/2022 | 08/21/2026 | 1645 | Injection | Endocrinology/Metabolism | ||
| 0264-7520-10 | Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Current | Available | 03/01/2022 | 08/21/2026 | 1645 | Injection | Endocrinology/Metabolism | ||
| 0264-7520-20 | Dextrose Monohydrate 10% Injection | B. Braun Medical Inc. | Current | Available | 03/01/2022 | 08/21/2026 | 1645 | Injection | Endocrinology/Metabolism | ||
| 0264-7387-50 | Dextrose Monohydrate 70% Injection | B. Braun Medical Inc. | Current | Available | 10/11/2024 | 08/21/2026 | 690 | Injection | Endocrinology/Metabolism | ||
| 0264-9872-00 | Heparin Sodium Injection | B. Braun Medical Inc. | Current | Available | 11/14/2017 | 08/21/2026 | 3213 | Injection | Hematology | ||
| 0264-9872-10 | Heparin Sodium Injection | B. Braun Medical Inc. | Current | Available | 11/14/2017 | 08/21/2026 | 3213 | Injection | Hematology | ||
| 0264-9594-10 | Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Current | Available | 10/25/2017 | 08/21/2026 | 3233 | Injection | Cardiovascular | ||
| 0264-9594-20 | Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Current | Available | 10/25/2017 | 08/21/2026 | 3233 | Injection | Cardiovascular | ||
| 0264-9598-20 | Lidocaine Hydrochloride Injection | B. Braun Medical Inc. | Current | Available | 10/25/2017 | 08/21/2026 | 3233 | Injection | Cardiovascular | ||
| 0264-2101-00 | Sterile Water Irrigant | B. Braun Medical Inc. | Current | Available | 04/28/2023 | 08/21/2026 | 1222 | Irrigant | Gastroenterology | ||
| 0264-2101-10 | Sterile Water Irrigant | B. Braun Medical Inc. | Current | Available | 04/28/2023 | 08/21/2026 | 1222 | Irrigant | Gastroenterology | ||
| 0338-0499-06 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 08/17/2026 | 2093 | Injection | Gastroenterology | ||
| 0338-0502-03 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 08/17/2026 | 2093 | Injection | Gastroenterology | ||
| 0338-0502-06 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 08/17/2026 | 2093 | Injection | Gastroenterology | ||
| 0338-0644-03 | Amino Acid Injection | Baxter Healthcare | Current | Unavailable | Estimated recovery: TBD | 12/08/2020 | 08/17/2026 | 2093 | Shortage of an inactive ingredient component | Injection | Gastroenterology |
| 0338-0644-04 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 08/17/2026 | 2093 | Injection | Gastroenterology | ||
| 0338-0644-06 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 08/17/2026 | 2093 | Injection | Gastroenterology | ||
| 0338-1130-03 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 08/17/2026 | 2093 | Injection | Gastroenterology | ||
| 0338-1130-04 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 08/17/2026 | 2093 | Injection | Gastroenterology | ||
| 0338-1130-06 | Amino Acid Injection | Baxter Healthcare | Current | Available | 12/08/2020 | 08/17/2026 | 2093 | Injection | Gastroenterology | ||
| 0338-3410-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Available | 03/21/2023 | 08/17/2026 | 1260 | Injection | Anti-Infective | ||
| 0338-3612-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Unavailable | Estimated recovery: October 2026 | 03/21/2023 | 08/17/2026 | 1260 | Other | Injection | Anti-Infective |
| 0338-3814-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Limited Availability | Estimated recovery: October 2026 | 03/21/2023 | 08/17/2026 | 1260 | Other | Injection | Anti-Infective |
| 0338-9545-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Available | 03/21/2023 | 08/17/2026 | 1260 | Injection | Anti-Infective | ||
| 0338-9549-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Available | 03/21/2023 | 08/17/2026 | 1260 | Injection | Anti-Infective | ||
| 0338-9553-50 | Clindamycin Phosphate Injection | Baxter Healthcare | Current | Available | 03/21/2023 | 08/17/2026 | 1260 | Injection | Anti-Infective | ||
| 0338-9555-24 | Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Current | Unavailable | Estimated recovery: September 2026 | 04/10/2020 | 08/17/2026 | 2335 | Other | Injection | Anesthesia |
| 0338-9557-12 | Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Current | Available | 04/10/2020 | 08/17/2026 | 2335 | Injection | Anesthesia | ||
| 43066-555-24 | Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Current | Available | 04/10/2020 | 08/17/2026 | 2335 | Injection | Anesthesia | ||
| 43066-557-12 | Dexmedetomidine Hydrochloride Injection | Baxter Healthcare | Current | Available | 04/10/2020 | 08/17/2026 | 2335 | Injection | Anesthesia | ||
| 0338-0017-02 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-03 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-10 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-11 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-18 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-31 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-38 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-41 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0017-48 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0070-10 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0074-30 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 07/20/2026 | 08/17/2026 | 43 | Injection | Endocrinology/Metabolism | ||
| 0338-0078-20 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0551-11 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0551-18 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-9664-40 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-9666-35 | Dextrose Monohydrate 5% Injection | Baxter Healthcare | Current | Available | 02/14/2022 | 08/17/2026 | 1660 | Injection | Endocrinology/Metabolism | ||
| 0338-0023-02 | Dextrose Monohydrate 10% Injection | Baxter Healthcare | Current | Available | 03/01/2022 | 08/17/2026 | 1645 | Injection | Endocrinology/Metabolism | ||
| 0338-0023-03 | Dextrose Monohydrate 10% Injection | Baxter Healthcare | Current | Available | 03/01/2022 | 08/17/2026 | 1645 | Injection | Endocrinology/Metabolism | ||
| 0338-0023-04 | Dextrose Monohydrate 10% Injection | Baxter Healthcare | Current | Available | 03/01/2022 | 08/17/2026 | 1645 | Injection | Endocrinology/Metabolism | ||
| 0338-0719-06 | Dextrose Monohydrate 70% Injection | Baxter Healthcare | Current | Unavailable | Estimated recovery: September 2026 | 10/11/2024 | 08/17/2026 | 690 | Other | Injection | Endocrinology/Metabolism |
| 0338-1073-02 | Dobutamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 08/17/2026 | 3221 | Injection | Cardiovascular | ||
| 0338-1075-02 | Dobutamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 08/17/2026 | 3221 | Injection | Cardiovascular | ||
| 0338-1077-02 | Dobutamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 08/17/2026 | 3221 | Injection | Cardiovascular | ||
| 0338-1005-02 | Dopamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 08/17/2026 | 3221 | Injection | Cardiovascular | ||
| 0338-1005-03 | Dopamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 08/17/2026 | 3221 | Injection | Cardiovascular | ||
| 0338-1007-02 | Dopamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 08/17/2026 | 3221 | Injection | Cardiovascular | ||
| 0338-1007-03 | Dopamine Hydrochloride Injection | Baxter Healthcare | Current | Available | 11/06/2017 | 08/17/2026 | 3221 | Injection | Cardiovascular | ||
| 36000-282-25 | Furosemide Injection | Baxter Healthcare | Current | Available | 04/07/2020 | 08/17/2026 | 2338 | Injection | Cardiovascular | ||
| 36000-283-25 | Furosemide Injection | Baxter Healthcare | Current | Available | 04/07/2020 | 08/17/2026 | 2338 | Injection | Cardiovascular | ||
| 36000-284-25 | Furosemide Injection | Baxter Healthcare | Current | Available | 04/07/2020 | 08/17/2026 | 2338 | Injection | Cardiovascular | ||
| 0338-0431-03 | Heparin Sodium Injection | Baxter Healthcare | Current | Available | 11/14/2017 | 08/17/2026 | 3213 | Injection | Hematology | ||
| 0338-0433-04 | Heparin Sodium Injection | Baxter Healthcare | Current | Available | 11/14/2017 | 08/17/2026 | 3213 | Injection | Hematology | ||
| 0338-3991-01 | Ifosfamide Injection | Baxter Healthcare | Current | Unavailable | Estimated recovery: October 2026 | 06/12/2026 | 08/17/2026 | 81 | Requirements related to complying with good manufacturing practices | Injection | Oncology |
| 0338-3993-01 | Ifosfamide Injection | Baxter Healthcare | Current | Unavailable | Estimated recovery: October 2026 | 06/12/2026 | 08/17/2026 | 81 | Requirements related to complying with good manufacturing practices | Injection | Oncology |
| 10019-925-01 | Ifosfamide Injection | Baxter Healthcare | Current | Unavailable | Estimated recovery: September 2026 | 06/12/2026 | 08/17/2026 | 81 | Requirements related to complying with good manufacturing practices | Injection | Oncology |
| 10019-926-02 | Ifosfamide Injection | Baxter Healthcare | Current | Unavailable | Estimated recovery: September 2026 | 06/12/2026 | 08/17/2026 | 81 | Requirements related to complying with good manufacturing practices | Injection | Oncology |
| 0338-0069-10 | Ketorolac Tromethamine Injection | Baxter Healthcare | Current | Unavailable | Estimated recovery: January 2027 | 06/06/2018 | 08/17/2026 | 3009 | Demand increase for the drug | Injection | Analgesia/Addiction |
| 0338-0072-25 | Ketorolac Tromethamine Injection | Baxter Healthcare | Current | Unavailable | Estimated recovery: October 2026 | 06/06/2018 | 08/17/2026 | 3009 | Demand increase for the drug | Injection | Analgesia/Addiction |
| 0338-0409-03 | Lidocaine Hydrochloride Injection | Baxter Healthcare | Current | Available | 10/25/2017 | 08/17/2026 | 3233 | Injection | Cardiovascular | ||
| 0338-0411-02 | Lidocaine Hydrochloride Injection | Baxter Healthcare | Current | Available | 10/25/2017 | 08/17/2026 | 3233 | Injection | Cardiovascular | ||
| 0338-1055-48 | Metronidazole Injection | Baxter Healthcare | Current | Available | 01/13/2022 | 08/17/2026 | 1692 | Injection | Anti-Infective | ||
| 43066-007-10 | Rocuronium Bromide Injection | Baxter Healthcare | Current | Available | 02/15/2023 | 08/17/2026 | 1294 | Injection | Anesthesia | ||
| 43066-013-10 | Rocuronium Bromide Injection | Baxter Healthcare | Current | Available | 02/15/2023 | 08/17/2026 | 1294 | Injection | Anesthesia | ||
| 0338-0004-02 | Sterile Water Irrigant | Baxter Healthcare | Current | Available | 04/28/2023 | 08/17/2026 | 1222 | Irrigant | Gastroenterology | ||
| 0338-0004-03 | Sterile Water Irrigant | Baxter Healthcare | Current | Limited Availability | Estimated recovery: August 2026 | 04/28/2023 | 08/17/2026 | 1222 | Demand increase for the drug | Irrigant | Gastroenterology |
| 0338-0004-04 | Sterile Water Irrigant | Baxter Healthcare | Current | Limited Availability | Estimated recovery: September 2026 | 04/28/2023 | 08/17/2026 | 1222 | Demand increase for the drug | Irrigant | Gastroenterology |
| 59572-102-01 | Azacitidine Injection | Bristol Myers Squibb Co. | Current | Available | 12/18/2020 | 08/16/2026 | 2083 | Injection | Oncology | ||
| 50633-310-11 | Hydroxocobalamin Injection | BTG International Inc. | Current | Limited Availability | Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage. | 11/04/2024 | 08/17/2026 | 666 | Other | Injection | Other |
| 65219-445-10 | Etomidate Injection | Caplin Steriles, Ltd. | Current | Available | Check wholesalers for inventory; Marketed by Fresenius Kabi | 10/05/2022 | 06/16/2026 | 1427 | Injection | Anesthesia | |
| 65219-447-20 | Etomidate Injection | Caplin Steriles, Ltd. | Current | Available | Check wholesalers for inventory; Marketed by Fresenius Kabi | 10/05/2022 | 06/16/2026 | 1427 | Injection | Anesthesia | |
| 72485-508-10 | Etomidate Injection | Caplin Steriles, Ltd. | Current | Available | Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586 | 10/05/2022 | 06/16/2026 | 1427 | Injection | Anesthesia | |
| 72485-509-10 | Etomidate Injection | Caplin Steriles, Ltd. | Current | Available | Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586 | 10/05/2022 | 06/16/2026 | 1427 | Injection | Anesthesia | |
| 43066-015-10 | Ropivacaine Hydrochloride Injection | Caplin Steriles, Ltd. | Current | Limited Availability | Check wholesalers for inventory; Marketed by Baxter | 12/22/2020 | 06/10/2026 | 2079 | Other | Injection | Anesthesia |
| 43066-019-10 | Ropivacaine Hydrochloride Injection | Caplin Steriles, Ltd. | Current | Available | Check wholesalers for inventory; Marketed by Baxter | 12/22/2020 | 06/10/2026 | 2079 | Injection | Anesthesia | |
| 43066-023-10 | Ropivacaine Hydrochloride Injection | Caplin Steriles, Ltd. | Current | Limited Availability | Limited supply; Check wholesalers for inventory; Marketed by Baxter | 12/22/2020 | 06/10/2026 | 2079 | Other | Injection | Anesthesia |
| 43066-027-10 | Ropivacaine Hydrochloride Injection | Caplin Steriles, Ltd. | Current | Available | Check wholesalers for inventory; Marketed by Baxter | 12/22/2020 | 06/10/2026 | 2079 | Injection | Anesthesia | |
| 62135-736-30 | Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Current | Available | 08/03/2022 | 08/26/2026 | 1490 | Capsule | Neurology | ||
| 62135-736-90 | Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Current | Available | 08/03/2022 | 08/26/2026 | 1490 | Capsule | Oncology | ||
| 62135-737-30 | Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Current | Available | 08/03/2022 | 08/26/2026 | 1490 | Capsule | Neurology | ||
| 62135-737-90 | Flurazepam Hydrochloride Capsule | Chartwell Molecular Holdings LLC | Current | Available | 08/03/2022 | 08/26/2026 | 1490 | Capsule | Neurology | ||
| 62135-484-60 | Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Current | Available | 01/19/2023 | 08/26/2026 | 1321 | Tablet | Cardiovascular | ||
| 62135-485-90 | Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Current | Available | 01/19/2023 | 08/26/2026 | 1321 | Tablet | Cardiovascular | ||
| 62135-486-90 | Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Current | Available | 01/19/2023 | 08/26/2026 | 1321 | Tablet | Cardiovascular | ||
| 62135-487-90 | Quinapril Hydrochloride Tablet | Chartwell Molecular Holdings LLC | Current | Available | 01/19/2023 | 08/26/2026 | 1321 | Tablet | Cardiovascular | ||
| 62135-667-90 | Quinapril/Hydrochlorothiazide Tablet | Chartwell Molecular Holdings LLC | Current | Available | 01/19/2023 | 08/26/2026 | 1321 | Tablet | Cardiovascular | ||
| 62135-668-90 | Quinapril/Hydrochlorothiazide Tablet | Chartwell Molecular Holdings LLC | Current | Available | 01/19/2023 | 08/26/2026 | 1321 | Tablet | Cardiovascular | ||
| 62135-669-90 | Quinapril/Hydrochlorothiazide Tablet | Chartwell Molecular Holdings LLC | Current | Available | 01/19/2023 | 08/26/2026 | 1321 | Tablet | Cardiovascular | ||
| 61269-605-10 | Clonazepam Tablet | Cheplapharm Arzneimittel GmbH | Current | Available | Marketed by H2-Pharma | 03/10/2023 | 08/17/2026 | 1271 | Tablet | Neurology | |
| 61269-610-10 | Clonazepam Tablet | Cheplapharm Arzneimittel GmbH | Current | Available | Marketed by H2-Pharma | 03/10/2023 | 08/17/2026 | 1271 | Tablet | Neurology | |
| 61269-620-10 | Clonazepam Tablet | Cheplapharm Arzneimittel GmbH | Current | Available | Marketed by H2-Pharma | 03/10/2023 | 08/17/2026 | 1271 | Tablet | Neurology | |
| 66220-160-10 | Conivaptan Hydrochloride Injection | Cumberland Pharmaceuticals Inc. | Current | Unavailable | Estimated recovery: TBD | 03/14/2022 | 08/18/2026 | 1632 | Delay in shipping of the drug | Injection | Cardiovascular |
| 69945-094-20 | Technetium TC-99M Pyrophosphate Kit Injection | Curium US LLC | Current | Limited Availability | Available via allocation | 12/27/2023 | 08/19/2026 | 979 | Shortage of an active ingredient | Injection | Medical Imaging |
| 43598-305-62 | Azacitidine Injection | Dr. Reddy's Laboratories, Inc. | Current | Available | Available to existing customers | 12/18/2020 | 08/05/2026 | 2083 | Injection | Oncology | |
| 70726-0303-1 | Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current | Unavailable | Next release not available at this time; Shortage per Manufacturer: Product manufacturing interrupted due to testing | 01/26/2024 | 08/17/2026 | 949 | Requirements related to complying with good manufacturing practices | Oral Suspension | Neurology |
| 70726-0304-1 | Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current | Available | 01/26/2024 | 08/17/2026 | 949 | Oral Suspension | Neurology | ||
| 70726-0305-1 | Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current | Available | 01/26/2024 | 08/17/2026 | 949 | Oral Suspension | Neurology | ||
| 70726-0306-1 | Riluzole Oral Suspension | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current | Available | 01/26/2024 | 08/17/2026 | 949 | Oral Suspension | Neurology | ||
| 64850-500-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 64850-501-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 64850-502-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 64850-503-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 64850-504-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 64850-505-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 64850-506-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Elite Laboratories, Inc. | Current | Available | 08/15/2023 | 08/17/2026 | 1113 | Tablet | Psychiatry | ||
| 64850-550-01 | Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Current | Limited Availability | Estimated recovery: TBD | 07/14/2023 | 08/17/2026 | 1145 | Shortage of an active ingredient | Capsule | Psychiatry |
| 64850-551-01 | Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Current | Limited Availability | Estimated recovery: TBD | 07/14/2023 | 08/17/2026 | 1145 | Shortage of an active ingredient | Capsule | Psychiatry |
| 64850-552-01 | Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Current | Limited Availability | Estimated recovery: TBD | 07/14/2023 | 08/17/2026 | 1145 | Shortage of an active ingredient | Capsule | Psychiatry |
| 64850-553-01 | Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Current | Limited Availability | Estimated recovery: TBD | 07/14/2023 | 08/17/2026 | 1145 | Shortage of an active ingredient | Capsule | Psychiatry |
| 64850-554-01 | Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Current | Limited Availability | Estimated recovery: TBD | 07/14/2023 | 08/17/2026 | 1145 | Shortage of an active ingredient | Capsule | Psychiatry |
| 64850-555-01 | Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Current | Limited Availability | Estimated recovery: TBD | 07/14/2023 | 08/17/2026 | 1145 | Shortage of an active ingredient | Capsule | Psychiatry |
| 64850-556-01 | Lisdexamfetamine Dimesylate Capsule | Elite Laboratories, Inc. | Current | Limited Availability | Estimated recovery: TBD | 07/14/2023 | 08/17/2026 | 1145 | Shortage of an active ingredient | Capsule | Psychiatry |
| 42806-339-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Epic Pharma, LLC | Current | Limited Availability | Estimated recovery: TBD | 10/12/2022 | 08/17/2026 | 1420 | Shortage of an active ingredient | Tablet | Psychiatry |
| 42806-341-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Epic Pharma, LLC | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 42806-343-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Epic Pharma, LLC | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 42806-344-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Epic Pharma, LLC | Current | Limited Availability | Estimated recovery: TBD | 10/12/2022 | 08/17/2026 | 1420 | Shortage of an active ingredient | Tablet | Psychiatry |
| 42806-345-01 | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Epic Pharma, LLC | Current | Available | 10/12/2022 | 08/17/2026 | 1420 | Tablet | Psychiatry | ||
| 42806-799-01 | Rifampin Capsule | Epic Pharma, LLC | Current | Unavailable | Discontinuation of the manufacture of the drug | 12/22/2021 | 08/17/2026 | 1714 | Discontinuation of the manufacture of the drug | Capsule | Anti-Infective |
| 42806-799-05 | Rifampin Capsule | Epic Pharma, LLC | Current | Unavailable | Discontinuation of the manufacture of the drug | 12/22/2021 | 08/17/2026 | 1714 | Discontinuation of the manufacture of the drug | Capsule | Anti-Infective |
| 42806-799-30 | Rifampin Capsule | Epic Pharma, LLC | Current | Unavailable | Discontinuation of the manufacture of the drug | 12/22/2021 | 08/17/2026 | 1714 | Discontinuation of the manufacture of the drug | Capsule | Anti-Infective |
| 42806-799-60 | Rifampin Capsule | Epic Pharma, LLC | Current | Available | 12/22/2021 | 08/17/2026 | 1714 | Capsule | Anti-Infective | ||
| 42806-801-01 | Rifampin Capsule | Epic Pharma, LLC | Current | Unavailable | Discontinuation of the manufacture of the drug | 12/22/2021 | 08/17/2026 | 1714 | Discontinuation of the manufacture of the drug | Capsule | Anti-Infective |
| 42806-801-30 | Rifampin Capsule | Epic Pharma, LLC | Current | Available | 12/22/2021 | 08/17/2026 | 1714 | Capsule | Anti-Infective | ||
| 68118-100-01 | Streptozocin Powder, For Solution | ESTEVE PHARMACEUTICALS, S.A. | Current | Available | 07/12/2022 | 05/06/2026 | 1512 | Powder, For Solution | Oncology | ||
| 55150-393-01 | Azacitidine Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 12/22/2020 | 08/06/2026 | 2079 | Demand increase for the drug | Injection | Oncology |
| 55150-167-10 | Bupivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-168-30 | Bupivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-169-10 | Bupivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-170-30 | Bupivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-171-10 | Bupivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-172-30 | Bupivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-249-50 | Bupivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-250-50 | Bupivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-335-01 | Carboplatin Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 04/28/2023 | 08/06/2026 | 1222 | Demand increase for the drug | Injection | Oncology |
| 55150-386-01 | Carboplatin Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 04/28/2023 | 08/06/2026 | 1222 | Injection | Oncology | |
| 55150-304-25 | Dexamethasone Sodium Phosphate Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/08/2019 | 08/06/2026 | 2762 | Injection | Dermatology | |
| 55150-209-02 | Dexmedetomidine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 04/10/2020 | 08/06/2026 | 2335 | Injection | Anesthesia | |
| 55150-296-10 | Dexmedetomidine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 04/10/2020 | 08/06/2026 | 2335 | Injection | Anesthesia | |
| 55150-297-10 | Dexmedetomidine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 04/10/2020 | 08/06/2026 | 2335 | Injection | Anesthesia | |
| 55150-221-10 | Etomidate Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 10/05/2022 | 08/06/2026 | 1427 | Demand increase for the drug | Injection | Anesthesia |
| 55150-222-20 | Etomidate Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 10/05/2022 | 08/06/2026 | 1427 | Demand increase for the drug | Injection | Anesthesia |
| 55150-322-25 | Furosemide Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 04/07/2020 | 08/06/2026 | 2338 | Demand increase for the drug | Injection | Cardiovascular |
| 55150-323-25 | Furosemide Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 04/07/2020 | 08/06/2026 | 2338 | Injection | Cardiovascular | |
| 55150-324-25 | Furosemide Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 04/07/2020 | 08/06/2026 | 2338 | Injection | Cardiovascular | |
| 55150-159-74 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Demand increase for the drug | Injection | Anesthesia |
| 55150-161-02 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-162-05 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-163-30 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-164-02 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-165-05 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/06/2026 | 3115 | Injection | Anesthesia | |
| 55150-251-10 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: end-August 2026. Check wholesalers for inventory | 06/13/2018 | 08/06/2026 | 3002 | Demand increase for the drug | Injection | Anesthesia |
| 55150-252-20 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 06/13/2018 | 08/06/2026 | 3002 | Injection | Anesthesia | |
| 55150-254-10 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 06/13/2018 | 08/06/2026 | 3002 | Demand increase for the drug | Injection | Anesthesia |
| 55150-255-20 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: mid-August 2026. Check wholesalers for inventory | 06/13/2018 | 08/06/2026 | 3002 | Demand increase for the drug | Injection | Anesthesia |
| 55150-256-50 | Lidocaine Hydrochloride Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 06/13/2018 | 08/06/2026 | 3002 | Demand increase for the drug | Injection | Anesthesia |
| 55150-313-01 | Methylprednisolone Acetate Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 12/15/2021 | 08/06/2026 | 1721 | Demand increase for the drug | Injection | Rheumatology |
| 55150-314-01 | Methylprednisolone Acetate Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 12/15/2021 | 08/06/2026 | 1721 | Demand increase for the drug | Injection | Rheumatology |
| 55150-225-05 | Rocuronium Bromide Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/15/2023 | 08/06/2026 | 1294 | Injection | Anesthesia | |
| 55150-226-10 | Rocuronium Bromide Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 02/15/2023 | 08/06/2026 | 1294 | Injection | Anesthesia | |
| 55150-195-20 | Ropivacaine Hydrochloride Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | 03/23/2018 | 08/06/2026 | 3084 | Demand increase for the drug | Injection | Anesthesia |
| 55150-196-99 | Ropivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 03/23/2018 | 08/06/2026 | 3084 | Injection | Anesthesia | |
| 55150-197-20 | Ropivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 03/23/2018 | 08/06/2026 | 3084 | Injection | Anesthesia | |
| 55150-198-30 | Ropivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 03/23/2018 | 08/06/2026 | 3084 | Injection | Anesthesia | |
| 55150-199-20 | Ropivacaine Hydrochloride Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: end-August 2026. Check wholesalers for inventory | 03/23/2018 | 08/06/2026 | 3084 | Demand increase for the drug | Injection | Anesthesia |
| 55150-200-10 | Ropivacaine Hydrochloride Injection | Eugia US LLC | Current | Unavailable | On backorder. Recovery: end-August 2026. Check wholesalers for inventory | 03/23/2018 | 08/06/2026 | 3084 | Demand increase for the drug | Injection | Anesthesia |
| 55150-201-20 | Ropivacaine Hydrochloride Injection | Eugia US LLC | Current | Available | Check wholesalers for inventory | 03/23/2018 | 08/06/2026 | 3084 | Injection | Anesthesia | |
| 51754-5001-5 | Sodium Bicarbonate Injection | Exela Pharma Sciences, LLC | Current | Available | 07/24/2017 | 07/22/2026 | 3326 | Injection | Endocrinology/Metabolism | ||
| 51754-5011-4 | Sodium Bicarbonate Injection | Exela Pharma Sciences, LLC | Current | Available | 07/24/2017 | 07/22/2026 | 3326 | Injection | Endocrinology/Metabolism | ||
| 51754-5012-4 | Sodium Bicarbonate Injection | Exela Pharma Sciences, LLC | Current | Available | 07/24/2017 | 07/22/2026 | 3326 | Injection | Endocrinology/Metabolism | ||
| 48102-053-05 | Echothiophate Iodide Ophthalmic Solution | Fera Pharmaceuticals | Current | Available | Available through limited distribution by Walgreens Specialty Pharmacy. | 09/24/2019 | 08/10/2026 | 2534 | Other | Ophthalmic Solution | Ophthalmology |
| 0053-6871-00 | Desmopressin Acetate Spray | Ferring | Current | Unavailable | Estimated recovery: TBD | 03/12/2021 | 05/01/2026 | 1999 | Requirements related to complying with good manufacturing practices | Spray | Hematology |
| 55566-2500-0 | Desmopressin Acetate Spray | Ferring | Current | Unavailable | Estimated recovery: TBD | 03/12/2021 | 05/01/2026 | 1999 | Requirements related to complying with good manufacturing practices | Spray | Hematology |
| 69918-501-05 | Desmopressin Acetate Spray | Ferring | Current | Unavailable | Estimated recovery: TBD | 03/12/2021 | 05/01/2026 | 1999 | Requirements related to complying with good manufacturing practices | Spray | Hematology |
| 63323-580-20 | Atropine Sulfate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 01/01/2012 | 08/25/2026 | 5357 | Injection | Anesthesia | |
| 63323-771-39 | Azacitidine Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Estimated recovery: TBD | 12/18/2020 | 08/25/2026 | 2083 | Demand increase for the drug | Injection | Oncology |
| 65219-570-04 | Bumetanide Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 01/31/2018 | 08/25/2026 | 3135 | Injection | Cardiovascular | |
| 65219-572-10 | Bumetanide Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 01/31/2018 | 08/25/2026 | 3135 | Injection | Cardiovascular | |
| 63323-460-37 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesaler for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-461-57 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesaler for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-462-17 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Current | Available | 7 month dating available on request. Check wholesalers for inventory. | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-462-31 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Estimated recovery: TBD | 02/20/2018 | 08/25/2026 | 3115 | Delay in shipping of the drug | Injection | Anesthesia |
| 63323-462-37 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-463-57 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesaler for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-468-17 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-468-37 | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesaler for inventory | 02/20/2018 | 08/25/2026 | 3115 | Other | Injection | Anesthesia |
| 63323-464-17 | Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-464-31 | Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Estimated recovery: TBD | 02/20/2018 | 08/25/2026 | 3115 | Demand increase for the drug | Injection | Anesthesia |
| 63323-464-37 | Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-465-57 | Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-466-17 | Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-466-31 | Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Estimated recovery: TBD | 02/20/2018 | 08/25/2026 | 3115 | Delay in shipping of the drug | Injection | Anesthesia |
| 63323-466-37 | Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-467-57 | Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-472-17 | Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-472-37 | Bupivacaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/20/2018 | 08/25/2026 | 3115 | Injection | Anesthesia | |
| 63323-172-60 | Carboplatin Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release November 2026. Check wholesalers for inventory. | 04/28/2023 | 08/25/2026 | 1222 | Delay in shipping of the drug | Injection | Oncology |
| 63323-165-01 | Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/08/2019 | 08/25/2026 | 2762 | Injection | Dermatology | |
| 63323-165-05 | Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/08/2019 | 08/25/2026 | 2762 | Injection | Dermatology | |
| 63323-165-30 | Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/08/2019 | 08/25/2026 | 2762 | Injection | Dermatology | |
| 63323-506-01 | Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/08/2019 | 08/25/2026 | 2762 | Injection | Dermatology | |
| 63323-516-10 | Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/08/2019 | 08/25/2026 | 2762 | Injection | Dermatology | |
| 76045-0210-10 | Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Current | Available | Checkwholesalers for inventory | 02/08/2019 | 08/25/2026 | 2762 | Injection | Dermatology | |
| 76045-210-10 | Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/08/2019 | 08/25/2026 | 2762 | Injection | Dermatology | |
| 76045-0212-10 | Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Current | Limited Availability | 4 month expiry available on request. Next release not available at this time. | 02/08/2019 | 08/25/2026 | 2762 | Demand increase for the drug | Injection | Dermatology |
| 76045-212-10 | Dexamethasone Sodium Phosphate Injection | Fresenius Kabi USA, LLC | Current | Limited Availability | 4 month expiry available on request. Next release not available at this time. | 02/08/2019 | 08/25/2026 | 2762 | Demand increase for the drug | Injection | Dermatology |
| 63323-421-02 | Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Estimated recovery: TBD | 04/10/2020 | 08/25/2026 | 2335 | Demand increase for the drug | Injection | Anesthesia |
| 63323-671-00 | Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Expected recovery: TBD | 04/10/2020 | 08/25/2026 | 2335 | Delay in shipping of the drug | Injection | Anesthesia |
| 63323-671-20 | Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Expected recovery: TBD | 04/10/2020 | 08/25/2026 | 2335 | Other | Injection | Anesthesia |
| 63323-671-50 | Dexmedetomidine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Estimated recovery: TBD | 04/10/2020 | 08/25/2026 | 2335 | Delay in shipping of the drug | Injection | Anesthesia |
| 65219-456-60 | Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholealers for inventory | 02/14/2022 | 08/25/2026 | 1660 | Injection | Endocrinology/Metabolism | |
| 65219-458-30 | Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/14/2022 | 08/25/2026 | 1660 | Injection | Endocrinology/Metabolism | |
| 65219-460-20 | Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/14/2022 | 08/25/2026 | 1660 | Demand increase for the drug | Injection | Endocrinology/Metabolism |
| 65219-462-10 | Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 02/14/2022 | 08/25/2026 | 1660 | Demand increase for the drug | Injection | Endocrinology/Metabolism |
| 65219-464-50 | Dextrose Monohydrate 5% Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/14/2022 | 08/25/2026 | 1660 | Injection | Endocrinology/Metabolism | |
| 63323-824-74 | Dextrose Monohydrate 10% Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 03/01/2022 | 08/25/2026 | 1645 | Injection | Endocrinology/Metabolism | |
| 63323-824-75 | Dextrose Monohydrate 10% Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 03/01/2022 | 08/25/2026 | 1645 | Injection | Endocrinology/Metabolism | |
| 63323-824-76 | Dextrose Monohydrate 10% Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 03/01/2022 | 08/25/2026 | 1645 | Injection | Endocrinology/Metabolism | |
| 63323-481-57 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 10/14/2016 | 08/25/2026 | 3609 | Demand increase for the drug | Injection | Anesthesia |
| 63323-482-17 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 10/14/2016 | 08/25/2026 | 3609 | Demand increase for the drug | Injection | Anesthesia |
| 63323-482-27 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 10/14/2016 | 08/25/2026 | 3609 | Injection | Anesthesia | |
| 63323-482-57 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release August 2026. Check wholesalers for inventory. | 10/14/2016 | 08/25/2026 | 3609 | Other | Injection | Anesthesia |
| 63323-483-27 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 10/14/2016 | 08/25/2026 | 3609 | Injection | Anesthesia | |
| 63323-483-57 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 10/14/2016 | 08/25/2026 | 3609 | Injection | Anesthesia | |
| 63323-487-17 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 10/14/2016 | 08/25/2026 | 3609 | Injection | Anesthesia | |
| 63323-487-37 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 10/14/2016 | 08/25/2026 | 3609 | Injection | Anesthesia | |
| 63323-488-17 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 10/14/2016 | 08/25/2026 | 3609 | Demand increase for the drug | Injection | Anesthesia |
| 63323-488-37 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 10/14/2016 | 08/25/2026 | 3609 | Injection | Anesthesia | |
| 63323-489-17 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 10/14/2016 | 08/25/2026 | 3609 | Injection | Anesthesia | |
| 63323-489-27 | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 10/14/2016 | 08/25/2026 | 3609 | Other | Injection | Anesthesia |
| 63323-806-01 | Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 01/01/2012 | 08/25/2026 | 5357 | Injection | Analgesia/Addiction | |
| 63323-806-02 | Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 01/01/2012 | 08/25/2026 | 5357 | Injection | Analgesia/Addiction | |
| 63323-806-05 | Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 01/01/2012 | 08/25/2026 | 5357 | Injection | Analgesia/Addiction | |
| 63323-806-20 | Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 01/01/2012 | 08/25/2026 | 5357 | Injection | Analgesia/Addiction | |
| 63323-806-50 | Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 01/01/2012 | 08/25/2026 | 5357 | Other | Injection | Analgesia/Addiction |
| 63323-808-11 | Fentanyl Citrate Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 01/01/2012 | 08/25/2026 | 5357 | Injection | Analgesia/Addiction | |
| 63323-280-02 | Furosemide Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 04/07/2020 | 08/25/2026 | 2338 | Injection | Cardiovascular | |
| 63323-280-04 | Furosemide Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 04/07/2020 | 08/25/2026 | 2338 | Injection | Cardiovascular | |
| 63323-280-10 | Furosemide Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 04/07/2020 | 08/25/2026 | 2338 | Injection | Cardiovascular | |
| 63323-519-10 | Heparin Sodium Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 11/14/2017 | 08/25/2026 | 3213 | Injection | Hematology | |
| 63323-519-77 | Heparin Sodium Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 11/14/2017 | 08/25/2026 | 3213 | Other | Injection | Hematology |
| 63323-851-10 | Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 10/31/2017 | 08/25/2026 | 3227 | Injection | Analgesia/Addiction | |
| 63323-851-15 | Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesaler for inventory | 10/31/2017 | 08/25/2026 | 3227 | Injection | Analgesia/Addiction | |
| 63323-851-50 | Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 10/31/2017 | 08/25/2026 | 3227 | Injection | Analgesia/Addiction | |
| 63323-852-25 | Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 10/31/2017 | 08/25/2026 | 3227 | Other | Injection | Analgesia/Addiction |
| 63323-853-25 | Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release October 2026. Check wholesalers for inventory. | 10/31/2017 | 08/25/2026 | 3227 | Other | Injection | Analgesia/Addiction |
| 63323-854-10 | Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 11/01/2017 | 08/25/2026 | 3226 | Injection | Analgesia/Addiction | |
| 76045-009-06 | Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release August 2026. Check wholesalers for inventory. | 10/31/2017 | 08/25/2026 | 3227 | Other | Injection | Analgesia/Addiction |
| 76045-009-11 | Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release October 2026. Check wholesalers for inventory. | 10/31/2017 | 08/25/2026 | 3227 | Other | Injection | Analgesia/Addiction |
| 76045-010-11 | Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release not available at this time. Check wholesalers for inventory. | 11/01/2017 | 08/25/2026 | 3226 | Other | Injection | Analgesia/Addiction |
| 76045-121-11 | Hydromorphone Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 11/01/2017 | 08/25/2026 | 3226 | Injection | Analgesia/Addiction | |
| 63323-142-10 | Ifosfamide Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release August 2026 | 06/12/2026 | 08/25/2026 | 81 | Demand increase for the drug | Injection | Oncology |
| 63323-161-01 | Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 03/23/2018 | 08/25/2026 | 3084 | Injection | Analgesia/Addiction | |
| 63323-162-01 | Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 03/23/2018 | 08/25/2026 | 3084 | Delay in shipping of the drug | Injection | Analgesia/Addiction |
| 63323-162-02 | Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 03/23/2018 | 08/25/2026 | 3084 | Delay in shipping of the drug | Injection | Analgesia/Addiction |
| 76045-104-10 | Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Estimated recovery: TBD | 03/23/2018 | 08/25/2026 | 3084 | Other | Injection | Analgesia/Addiction |
| 76045-105-20 | Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Estimated recovery: TBD | 03/23/2018 | 08/25/2026 | 3084 | Other | Injection | Analgesia/Addiction |
| 76045-107-10 | Ketorolac Tromethamine Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Estimated recovery: TBD | 03/23/2018 | 09/01/2026 | 3086 | Other | Injection | Analgesia/Addiction |
| 63323-201-02 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/22/2012 | 08/25/2026 | 5305 | Injection | Anesthesia | |
| 63323-201-10 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release October 2026. Check wholesalers for inventory. | 02/22/2012 | 08/25/2026 | 5305 | Demand increase for the drug | Injection | Anesthesia |
| 63323-202-02 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/22/2012 | 08/25/2026 | 5305 | Injection | Anesthesia | |
| 63323-208-05 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 02/22/2012 | 08/25/2026 | 5305 | Demand increase for the drug | Injection | Anesthesia |
| 63323-484-57 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Estimated recovery: TBD | 02/22/2012 | 08/25/2026 | 5305 | Demand increase for the drug | Injection | Anesthesia |
| 63323-485-27 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/22/2012 | 08/25/2026 | 5305 | Injection | Anesthesia | |
| 63323-485-57 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/22/2012 | 08/25/2026 | 5305 | Injection | Anesthesia | |
| 63323-486-17 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/22/2012 | 08/25/2026 | 5305 | Injection | Anesthesia | |
| 63323-486-27 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Unavailable | Next release September 2026. Check wholesalers for inventory. | 02/22/2012 | 08/25/2026 | 5305 | Demand increase for the drug | Injection | Anesthesia |
| 63323-486-57 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/22/2012 | 08/25/2026 | 5305 | Injection | Anesthesia | |
| 63323-491-57 | Lidocaine Hydrochloride Injection | Fresenius Kabi USA, LLC | Current | Available | Check wholesalers for inventory | 02/22/2012 | 08/25/2026 | 5305 | Injection | Anesthesia |
Showing the first 400 of 1,186 records. Every record has its own page, with its source and the quoted line that states it; these list the rest.
- Records 1–40016729-483-03 · Atropine Sulfate Injection · Accord Healthcare Inc. … 63323-491-57 · Lidocaine Hydrochloride Injection · Fresenius Kabi USA, LLC
- Records 401–80063323-492-27 · Lidocaine Hydrochloride Injection · Fresenius Kabi USA, LLC … 0527-0760-37 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · Lannett Company, Inc.
- Records 801–1,1860527-0761-37 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · Lannett Company, Inc. … 39822-4200-6 · Rocuronium Bromide Injection · XGen Pharmaceuticals DJB, Inc.
Where this came from
Every record above links the page it was taken from and quotes the sentence that states it. These are the 292 sources this dataset was assembled from.
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ailex%20Pharmaceuticals%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alembic%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22American%20Regent,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Anthea%20Pharma%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Armas%20Pharmaceuticals%20Inc%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avyxa%20Pharma,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Azurity%20Pharmaceuticals,%20Inc%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Bristol%20Myers%20Squibb%20Co.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22BTG%20International%20Inc.%22+AND+generic_name%3A%22Hydroxocobalamin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cheplapharm%20Arzneimittel%20GmbH%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cumberland%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Conivaptan%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Curium%20US%20LLC%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Dr.%20Reddy%27s%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22EDW%20Pharma,%20Inc.%20(formerly%20Italfarmaco%20Pharma,%20Inc.)%22+AND+generic_name%3A%22Riluzole%20Oral%20Suspension%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22ESTEVE%20PHARMACEUTICALS,%20S.A.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Exela%20Pharma%20Sciences,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fera%20Pharmaceuticals%22+AND+generic_name%3A%22Echothiophate%20Iodide%20Ophthalmic%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ferring%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hainan%20Poly%20Pharm.%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Pentostatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22HQ%20Specialty%20Pharma%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Huons%20Co.,%20Ltd%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Huons%20Co.,%20Ltd.%20(South%20Korea)%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Janssen%20Pharmaceuticals%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.%20(US%20Agent%20eVenus%20Pharmaceutical%20Laboratories,%20Inc.)%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Kindos%20Pharmaceuticals%20Co.%20Ltd.%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Laboratorios%20Atral%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lifsa%20Drugs%20LLC%22+AND+generic_name%3A%22Isocarboxazid%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Long%20Grove%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medefil,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medefil,%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medexus%22+AND+generic_name%3A%22Triamcinolone%20Hexacetonide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Micro%20Labs%20LTD%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Milla%20Pharmaceuticals%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22MSN%20Laboratories%20Private%20Limited%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mullan%20Pharmaceutical%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Specialty,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Nephron%20Pharmaceuticals%20Corporation%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Noven%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Film,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22ONESOURCE%20SPECIALTY%20PTE%20LTD%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Padagis%20US%20LLC%22+AND+generic_name%3A%22Bacitracin%20Ophthalmic%20Ointment%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sanofi-Aventis%20U.S.%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Spectra%20Medical%20Devices,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydroxocobalamin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teyro%20Labs%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22WG%20Critical%20Care%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
Machine-readable
- data.jsonThe whole dataset — every record with its source URL and source quote.
- Open Knowledge Format bundleOne JSON object per line — every record's frontmatter and quoted span exactly as it is held here, in one fetch.
- data.csvThe same records as one flat table, for a spreadsheet or a dataframe. The last four columns are the source URL, the quoted sentence it was read from, the date we last checked it, and which columns are our reading rather than the page's words.
- How this is made and checkedWhat "verified against source" does and does not mean.
From your own code
Same records, same quotes, without scraping the page: refsource is on PyPI and npm. Each value comes back carrying the URL it was read from and the sentence on that page that states it — .source and .quote sit on the value itself rather than in a side channel, so the checking step is available instead of skipped.
pip install refsource
refsource lookup drug-shortage-duration-tracker generic_name="Atropine Sulfate Injection"
npx -y refsource lookup drug-shortage-duration-tracker generic_name="Atropine Sulfate Injection"
Set your AI assistant up to use this
Two files and no account. Put this in .mcp.json at the root of your project — Claude Code, Cursor, Windsurf, VS Code and Codex all read that file — and your assistant can look this dataset up instead of recalling it. The server is remote, keyless and read-only.
{
"mcpServers": {
"referencesource": {
"type": "http",
"url": "https://referencesource.org/mcp"
}
}
}Add to Cursor · or, on the command line: claude mcp add --transport http referencesource https://referencesource.org/mcp --scope project
Then one line in the project's CLAUDE.md or AGENTS.md, so the assistant knows when to reach for it:
When a question needs "FDA drug shortage duration tracker", call the referencesource MCP server at https://referencesource.org/mcp (tool `search_records`, dataset_slug `drug-shortage-duration-tracker`) instead of answering from memory — every record it returns carries its source URL and a verbatim quote from that page.What each tool does, and the servers built over single registers: Connect your AI assistant.